XML 39 R29.htm IDEA: XBRL DOCUMENT
v3.22.2

Financial Instruments and Risk Management (Tables) | 9 Months Ended
--- | ---
Jun. 25, 2022
Fair Value Disclosures [Abstract] |
Fair value of the Partnership's derivative instruments and their location in the condensed consolidated balance sheets | The following summarizes the fair value of the Partnership’s derivative instruments and their location in the condensed consolidated balance sheets as of June 25, 2022 and September 25, 2021, respectively:
|  | As of June 25, 2022 |  |  | As of September 25, 2021 |
Asset Derivatives |  | Location |  | Fair Value |  |  | Location |  | Fair Value |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |
Commodity-related derivatives |  | Other current assets |  | $ | 49,993 |  |  | Other current assets |  | $ | 53,019 |
|  | Other assets |  |  | 3,095 |  |  | Other assets |  |  | 1,813 |
|  |  |  | $ | 53,088 |  |  |  |  | $ | 54,832 |
Liability Derivatives |  | Location |  | Fair Value |  |  | Location |  | Fair Value |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |
Commodity-related derivatives |  | Other current liabilities |  | $ | 11,163 |  |  | Other current liabilities |  | $ | 8,715 |
|  | Other liabilities |  |  | 1,487 |  |  | Other liabilities |  |  | 1,632 |
|  |  |  | $ | 12,650 |  |  |  |  | $ | 10,347 |
Reconciliation of the beginning and ending balances of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs | The following summarizes the reconciliation of the beginning and ending balances of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs:
|  | Fair Value Measurement Using Significant Unobservable Inputs (Level 3) |
|  | Nine Months Ended |  |  | Nine Months Ended |
|  | June 25, 2022 |  |  | June 26, 2021 |
|  | Assets |  |  | Liabilities |  |  | Assets |  |  | Liabilities |
Beginning balance of over-the-counter options |  | $ | 4,626 |  |  | $ | 451 |  |  | $ | — |  |  | $ | — |
Beginning balance realized during the period |  |  | (4,626 | ) |  |  | (78 | ) |  |  | — |  |  |  | — |
Contracts purchased during the period |  |  | 654 |  |  |  | 2,378 |  |  |  | 2,675 |  |  |  | 182 |
Change in the fair value of outstanding contracts |  |  | — |  |  |  | (280 | ) |  |  | — |  |  |  | — |
Ending balance of over-the-counter options |  | $ | 654 |  |  | $ | 2,471 |  |  | $ | 2,675 |  |  | $ | 182 |
Effect of the Partnership's derivative instruments on the condensed consolidated statements of operations | The effect of the Partnership’s derivative instruments on the condensed consolidated statements of operations for the three and nine months ended June 25, 2022 and June 26, 2021 are as follows:
|  | Three Months Ended June 25, 2022 |  |  | Three Months Ended June 26, 2021 |
Derivatives Not Designated as Hedging Instruments |  | Unrealized Gains (Losses) Recognized in Income |  |  | Unrealized Gains (Losses) Recognized in Income |
|  | Location |  | Amount |  |  | Location |  | Amount |
Commodity-related derivatives |  | Cost of products sold |  | $ | (921 | ) |  | Cost of products sold |  | $ | 11,139 |
|  | Nine Months Ended June 25, 2022 |  |  | Nine Months Ended June 26, 2021 |
Derivatives Not Designated as Hedging Instruments |  | Unrealized Gains (Losses) Recognized in Income |  |  | Unrealized Gains (Losses) Recognized in Income |
|  | Location |  | Amount |  |  | Location |  | Amount |
Commodity-related derivatives |  | Cost of products sold |  | $ | (1,442 | ) |  | Cost of products sold |  | $ | 17,632 |
Fair value of the Partnership's recognized derivative assets and liabilities on a gross basis and amounts offset on the condensed consolidated balance sheets | The following table presents the fair value of the Partnership’s recognized derivative assets and liabilities on a gross basis and amounts offset on the condensed consolidated balance sheets subject to enforceable master netting arrangements or similar agreements:
|  | As of June 25, 2022 |  |  | As of September 25, 2021 |
|  |  |  |  |  |  |  | Net amounts |  |  |  |  |  |  |  |  | Net amounts |
|  |  |  |  |  |  |  | presented in the |  |  |  |  |  |  |  |  | presented in the |
|  | Gross amounts |  |  | Effects of netting |  |  | balance sheet |  |  | Gross amounts |  |  | Effects of netting |  |  | balance sheet |
Asset Derivatives |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commodity-related derivatives |  | $ | 88,867 |  |  | $ | (35,779 | ) |  | $ | 53,088 |  |  | $ | 76,508 |  |  | $ | (21,676 | ) |  | $ | 54,832 |
Liability Derivatives |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commodity-related derivatives |  | $ | 48,429 |  |  | $ | (35,779 | ) |  | $ | 12,650 |  |  | $ | 32,023 |  |  | $ | (21,676 | ) |  | $ | 10,347 |
Fair Value of the Partnership's Senior Notes | Based upon quoted market prices (a Level 1 input), the fair value of the Senior Notes (also defined below in Note 10) of the Partnership are as follows:
|  | As of |
|  | June 25, |  |  | September 25, |
|  | 2022 |  |  | 2021 |
5.875% senior notes due March 1, 2027 |  |  | 330,925 |  |  |  | 367,063 |
5.0% senior notes due June 1, 2031 |  |  | 560,625 |  |  |  | 676,000 |
|  | $ | 891,550 |  |  | $ | 1,043,063 |

X
- Definition Tabular disclosure of fair value of Senior Notes. + References No definition available. + Details
Name: | sph_FairValueOfSeniorNotesTableTextBlock
Namespace Prefix: | sph_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative and other financial assets and liabilities that are subject to offsetting, including master netting arrangements. + References No definition available. + Details
Name: | sph_OffsettingAssetsAndLiabilitiesTableTextBlock
Namespace Prefix: | sph_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4E -URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration